Hirofumi Maruyama

Author PubWeight™ 0.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2020 3.93